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Abstract The aim of the study was to investigate which
factors are associated with age at onset in bipolar disorder
with a speciﬁc focus on excessive alcohol and cannabis use,
and the sequence of the onsets of excessive substance use
and bipolar disorder. We investigated a naturalistic sample
of 151 patients with bipolar I and II disorder receiving
psychiatric treatment. Whether the presence of excessive
substance use prior to bipolar disorder onset or the type of
substance used (alcohol or cannabis) was associated with
differences in age at onset was investigated using hierar-
chical and multiple linear regression analyses, adjusting for
potential confounders. Patients with excessive alcohol use
had a signiﬁcantly later onset compared with patients with
excessive cannabis use. Excessive general substance use
prior to bipolar disorder onset was associated with a later
onset. However, excessive cannabis use was associated with
an earlier onset whether it preceded or followed bipolar
disorder onset, also after adjusting for possible confounders.
Excessive use of alcohol or other substances was not
independently associated with age at onset in multivariate
analyses. Alcohol use was associated with a later onset
compared with cannabis use, suggesting different relation-
ships to the onset of bipolar disorder. Lifetime use of can-
nabis predicted an earlier onset, independent of the
sequence of onsets. This indicates that an early onset may
increase the risk of cannabis use and that cannabis use may
trigger bipolar disorder in vulnerable individuals.
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Introduction
The age at onset (AAO) of bipolar disorder (BD) varies
from adolescence to mid-adulthood [1], but the reasons for
the variation are not fully known. Recent studies ﬁnd dif-
ferences in AAO between research sites, with early AAO
more often reported from US studies than from European
studies [2–4] even though there are exceptions [3, 5, 6].
These variations have been attributed to factors ranging
from differences in genetic loading to recruitment biases or
methodological discrepancies [2, 6, 7] such as the deﬁni-
tion of illness onset.
However, several other factors have been shown to
affect AAO in BD. A family history of affective disorder
has been associated with an early onset [8–10]. Most
studies ﬁnd a similar AAO for men and women [11], while
some report earlier onsets in females [12, 13] and others
earlier onsets in men with BD I [3]. The subtypes of BD
(BD I and II) appear to have a similar AAO [14]; however,
earlier onsets in either BD I or II were also recently
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trauma were associated with an earlier onset [15, 16].
The relationship between substance abuse and AAO in
BD is poorly understood. The risk for substance abuse
(especially of illicit substances) appears to be increased for
patients with childhood- and adolescent onset compared
with adult onset [13, 17–21], and it has been hypothesized
that AAO and substance abuse may share a common
genetic etiology [13]. These studies, however, did not
differentiate between the types of substances used. Alcohol
and cannabis are the two most frequently used substances
in BD [22–25]. To the best of our knowledge, the associ-
ation between type of substance of abuse (alcohol or can-
nabis) and AAO has not been investigated in previous
studies.
Substance abuse may both be a cause and a consequence
of early BD onset. One line of research has investigated
whether differences in AAO depend on the sequence of the
onsets of BD and substance abuse. A later onset has been
found among patients with substance abuse that precedes
the BD [26–31]. There is also evidence for a less severe
clinical course [28, 32–34] and lower rates of family his-
tory of affective illness [27] in BD secondary to substance
abuse. The later onset, less severe clinical course, and
lower rates of family history in patients with BD secondary
to substance abuse have been considered markers of a
lower constitutional vulnerability and lead to the hypoth-
esis that substance abuse could be necessary for a mani-
festation of BD in these individuals [27, 28, 32]. Most
studies have focused on either alcohol abuse or substance
abuse in general, and the potential to precipitate BD has
been proposed both for alcohol [32, 35], cannabis [29], and
even for any substance of abuse [34].
The pharmacological effects of various substances of
abuse are often different, and alcohol and cannabis appear
to have different effects on the course of an established
BD. In a prospective study, cannabis use coincided with or
preceded hypomanic or manic symptoms, while alcohol
use coincided with or preceded depressive symptoms [36].
Recently, there has been focus on the relationship between
BD and cannabis use in prospective epidemiologic studies.
These indicate that cannabis use in the general population
is associated with development of manic symptoms [37,
38] and that lifetime cannabis use is associated with a
ﬁvefold increase in the risk of developing BD [39].
Only one study has investigated the sequence of the
onsets of BD and cannabis use disorders and its relation-
ship to AAO. This indicated that patients with a primary
cannabis use disorder had a later onset compared to
patients with no cannabis use disorder or a secondary
cannabis use disorder [29]. This has not been replicated,
and there is a need for further studies that simultaneously
evaluate the associations between AAO and excessive
alcohol or cannabis use. It is here of particular interest
whether the excessive substance use was present before the
BD onset.
In the present study, we investigated a sample of 151
patients with BD. We had the following research questions:
(1) Does AAO differ between patients with excessive
alcohol use, excessive cannabis use and patients using
neither of these substances?
(2) Do type of excessive substance use (i.e. alcohol or
cannabis) and the presence of excessive substance use
prior to the BD onset independently predict AAO
after adjusting for possible confounders? (Table 1).
Methods and materials
Participants
A hundred and ﬁfty-one patients with DSM-IV diagnosed
bipolar disorder (BD I n = 91 and BD II n = 60) partici-
pated in the study. This patient sample is part of an ongoing
study of schizophrenia and BD (the Thematically Orga-
nized Psychosis (TOP) study). Patients were recruited
consecutively from the psychiatric units (inpatient and
outpatient) of the three major hospitals in Oslo from 2003
to 2008. Participants were excluded if they had a history of
moderate/severe head injury, neurological disorder, devel-
opmental delays, age outside of 18–65 years or if they did
not speak a Scandinavian language. All participants gave
informed consent, and the project was approved by the
Regional Committee for Medical Research Ethics as well
as the Norwegian Data Inspectorate. Data on the relation-
ship between AAO, illness severity and time to ﬁrst treat-
ment for parts of this sample are reported elsewhere [7].
Clinical assessment
Clinical assessments were carried out by trained clinical
psychologists and psychiatrists. Diagnoses were estab-
lished using the Structured Clinical Interview for DSM-IV
(SCID), modules A-E (American Psychiatric Association,
1994). All interviewers were trained based on the training
program at UCLA CA, USA, and participated in regular
diagnostic consensus meetings. A good inter-rater reli-
ability was achieved with an overall kappa score of 0.77
(95% CI: 0.60-0.94). AAO was deﬁned as the age when the
ﬁrst SCID-veriﬁed affective episode (depressive, hypo-
manic, manic, or mixed) began. Sociodemographic and
clinical variables were cross-checked with participants’
medical charts and with information from interviews with
close family members if relevant. A family history of
depression, BD, schizophrenia, and other psychotic
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123disorders among ﬁrst-degree relatives (i.e. mother, father,
brothers, and sisters) was obtained through patient inter-
views. Patients having a minimum of one ﬁrst-degree rel-
ative with one or more psychiatric disorders were
considered to have a family history. A family history of
other psychotic disorders than BD was considered since
several recent studies have shown common heritability for
BD and schizophrenia [40, 41]. A family history was col-
lected for 148 of the patients. Of these, 62 (42%) had a
positive family history of any lifetime affective or psy-
chotic disorder, 41 (27%) of depression, 20 (14%) of BD,
and 6 (4%) of psychotic disorder. Four patients had a
family history of both BD and depression, and one patient
had a family history of both BD and psychosis.
Substance use assessments
Each patient reported lifetime substance use (daily, weekly,
monthly, or occasional/no use) for all substances for the
following life periods: 11–15 years, 16–20 years,
21–27 years, 28–44 years, 45–60 years, and 60? years.
Patients that either 1) met criteria for a DSM-IV substance
use disorder (SUD) or 2) had predominantly daily use of
alcohol and/or predominantly weekly use of a non-alco-
holic substance through at least one of the life periods
above (i.e. for a minimum of 4 years) were considered
excessive substance users and included as such in the
subsequent analyses. In an earlier study, we have shown
that the use patterns and correlates of excessive substance
Table 1 Summary of previous ﬁndings highly relevant for the present study’s research questions
Authors, publication Material/methods Finding
Carlson et al. [17] N = 43 (psychotic mania), clinical, 24-month follow-up Childhood and adolescent BD
onset is associated with
increased risk for substance use
disorders
Carter et al. [20] N = 320 (229 BD I, 91 BD II), clinical, cross-sectional
Ernst et al. [18] N = 56 (46 BD I, 7 BD II, 3 BD NOS), clinical, cross-sectional
Goldstein et al. [21] N = 1,411 (BD), epidemiological, cross-sectional
Lin et al. [13] N = 717 (510 BD I, 155 BD II, 52 schiz.aff.), family study, cross-sectional
Perlis et al. [19] N = 983 (703 BD I, 239 BD II, 40 BD NOS), clinical, cross-sectional
Feinman et al. [26] N = 188 (82 BD I, 42 BD II, 26 cycl., 38 BD NOS), clinical, cross-sectional Substance use disorders preceding
BD are associated with a later
BD onset
DelBello et al. [27] N = 51 (BD I), clinical, cross-sectional
Fossey et al. [30] N = 1,000 (710 BD I, 240 BD II, 40 BD NOS), clinical, cross-sectional
Strakowski et al. [31] N = 59 (psychotic mania), clinical, cross-sectional
Strakowski et al. [28] N = 144 (BD I), clinical, 5-year follow-up Alcohol use disorders preceding
BD are associated with a later
BD onset
Strakowski et al. [29] N = 144 (BD I), clinical, 5-year follow-up Cannabis use disorders preceding
BD are associated with a later
BD onset
Goldstein and Levitt [33] N = 657 (BD I), epidemiological, cross-sectional Alcohol use disorders preceding
BD are associated with a less
severe BD course
Strakowski et al. [28] N = 144 (BD I), clinical, 5-year follow-up
Winokur et al. [32] N = 231 (BD I and schizoaffective manic), clinical, 5-year follow-up
Pacchiarotti et al. [34] N = 289 (186 BD I, 103 BD II), clinical, cross-sectional Substance use disorders preceding
BD are associated with a less
severe BD course
DelBello et al. [27] N = 51 (BD I), clinical, cross-sectional Substance use disorders preceding
BD are associated with lower
rates of family history of
affective disorders
Baethge et al. [36] N = 166 (BD I), clinical, 4.7-year follow-up Cannabis use coincides with or
precedes (hypo)manic
symptoms, while alcohol
coincides with or precedes
depressive symptoms
Henquet et al. [37] N = 4,815 (general population sample), epidemiological, 3-year follow-up Cannabis use is associated with an
increased risk for developing
manic symptoms
Tijssen et al. [38] N = 1,395 (14-17 year olds, population sample), epidemiological,
8-year follow-up
Van Laar et al. [39] N = 3,881 (general population sample), epidemiological, 3-year follow-up Cannabis use is associated with an
increased risk for developing BD
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123use are similar for patients with SUD and patients with
excessive substance use according to deﬁnition above [42].
Age at onset of excessive substance use was deemed to
be either 1) the age when DSM-IV abuse/dependence cri-
teria were ﬁrst met or 2) the age when the patient started
daily use of alcohol or weekly use of (a) non-alcoholic
substance(s). Twenty-eight patients (19%) had excessive
use of alcohol, 24 patients (16%) had excessive use of
cannabis, and 11 patients used both. Patients who used both
were similar to the patients who used cannabis only and not
to the patients who used alcohol only for all relevant
clinical and sociodemographic characteristics and were
therefore grouped together with the cannabis-only patients
in the bivariate analyses for research question 1. But to
further ensure that the differences between the alcohol and
the cannabis groups were not due to the characteristics of
the patients using both alcohol and cannabis, follow-up
analyses were conducted where these patients were
excluded. Among the 88 patients with neither excessive
alcohol nor cannabis use, three patients had excessive use
of other substances, which were excluded from the bivar-
iate analyses.
Sequencing of onsets of BD and excessive substance
use
For research question 2, the total sample was subdivided
into two groups based on the presence (secondary BD) or
absence (primary BD) of excessive substance use prior to
the ﬁrst affective episode. This dichotomous variable is
subsequently referred to as the sequencing of onsets. The
small group of patients (n = 6) whose onsets of the ﬁrst
affective episode and excessive substance use occurred
within the same year were categorized as secondary BD.
This was done because excessive substance use to a greater
degree than BD has a gradual rather than an abrupt onset.
Since all patients in this study eventually were diagnosed
with BD, affective episodes associated with substance use
in patients with no previous BD episode were used as
markers for AAO. Using these criteria, 117 (77%) patients
had primary BD and 34 (23%) had secondary BD. Patients
with primary BD could theoretically develop excessive
substance use after the onset of BD, and data showed that
32 patients (21%) subsequently did. Sociodemographic and
clinical characteristics in the two groups are described in
Table 2.
Statistical analysis
All analyses were done using the Statistical Package for the
Social Sciences (SPSS) version 16.0 (Inc., Chicago, IL,
USA). Statistical signiﬁcance was determined using the
0.05 level and 2-tailed tests of signiﬁcance. One-way
ANOVAs with Tukey’s post hoc tests were used to com-
pare the groups on continuous variables. Dichotomous
variables were analyzed with chi-square tests with corre-
sponding post hoc analyses performed using chi-squares
with a Bonferroni corrected alpha level for the three group
comparisons set to 0.017. Pearson correlations were used to
assess bivariate associations between the dependent and the
independent variables. A two-way ANOVA was used to
investigate the possible interaction effects of type of sub-
stance use and sequencing. The contributions of the inde-
pendent variables were then further explored with multiple
regression analyses. Possible confounders of the relation-
ships between AAO and type of substance or sequencing
were chosen on the basis of differences found in bivariate
analyses and ﬁndings from earlier studies. They were
identiﬁed as gender, type of BD (I versus II), a family
history of affective/psychotic disorders, and excessive use
of other substances than alcohol or cannabis. Possible
mediators that did not show signiﬁcant or trend level
Table 2 Sociodemographic and clinical characteristics in primary BD and secondary BD
Primary BD Secondary BD Statistics
N = 117 N = 34
Age, y, mean (SD) 36.50 (12.2) 33.7 (10.4) t = 1.2, df = 149, P = 0.227
a
AAO, y, mean (SD) 21.8 (9.0) 25.9 (9.8) t =- 2.3, df = 149, P = 0.020
a
Age at onset of excessive substance use, y, mean (SD)* 27.0 (11.6) 20.1 (7.0) t = 2.9, df = 64, P = 0.005
a
Gender, female, n (%) 74 (63.2) 18 (52.9) v
2 = 1.2, df = 1, P = 0.278
b
Type I BD, (%) 68 (58.1) 23 (67.6) v
2 = 1.0, df = 1, P = 0.318
b
Family history of affective/psychotic disorder, n(%) 45 (39) 17 (52) v
2 = 1.6, df = 1, P = 0.204
b
Signiﬁcant P-values are typed in bold
BD Bipolar disorder, AAO Age at onset of BD, y Years
* For the 32 patients with excessive substance use in the primary BD group
a Student’s t-test
b Chi-square test
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123effects were not entered in the ﬁnal model. In the present
material, age was highly correlated with AAO due to the
focus on including mainly non-chronic patients in the
study. Since preferred substance (alcohol or cannabis)
may be a cohort phenomenon and inﬂuence AAO, age
was still entered into the model. This model provided a
better mathematical ﬁt despite the colinearity. The vari-
ance accounted for by some of the other variables was,
however, reduced. The analysis was performed hierar-
chically with several steps: ﬁrst, gender and age; second,
BD type and family history of affective/psychotic disor-
ders; third, sequencing; and fourth, excessive alcohol and
cannabis use. Reported are increase in R
2 at each step,
beta values, and their corresponding statistics from the
ﬁnal model.
Results
Patients with excessive alcohol use had a signiﬁcantly later
onset compared to patients with excessive cannabis use and
showed a trend in the same direction relative to the non-
users (Table 3). Excessive alcohol users and non-users
were older than the cannabis users. The excessive alcohol
users also had a signiﬁcantly later onset of the excessive
substance use than the cannabis users. The proportion of
patients with a family history of affective or psychotic
disorders was signiﬁcantly higher among the cannabis
users compared with the alcohol users. There was a trend
toward a greater proportion of females among the non-
users compared with the alcohol users. Follow-up analyses
excluding patients using both alcohol and cannabis did not
give any changes regarding group wise differences for age,
AAO and age at onset of excessive substance use, or for the
proportion with BD I or a family history of affective/
psychotic disorder. The difference in the proportion with
excessive use of other substances was, however, no longer
signiﬁcant (18% vs. 25%, v
2 = 0.40, P = 0.53), implying
that excessive polysubstance use was a characteristic of the
excluded group.
AAO was earlier for primary BD compared with sec-
ondary BD (21.8 ± 9.0 vs. 25.9 ± 9.8, P = 0.02)
(Table 2) and for cannabis users compared with alcohol
users (19.5 ± 5.4 vs. 27.9 ± 11.8, P = 0.005) (Table 3)i n
both primary and secondary BD as illustrated in Fig. 1.
There were no interaction effects between sequencing and
type of substance use.
Table 3 Sociodemographic and clinical characteristics of patients with excessive alcohol use, excessive cannabis use, or no excessive substance
use
No use,
n = 85 (A)
Alcohol use,
n = 28 (B)
Cannabis use,
n = 35 (C)
Statistics
Age, y, mean (SD) 36.6 (12.0) 42.0 (11.9) 29.2 (7.5) F = 10.9, df = 2,150, P < 0.001,A ,B[C
(trend A\B)
AAO, y, mean (SD) 22.5 (9.1) 27.0 (11.8) 19.5 (5.4) F = 5.5, df = 2,150, P = 0.005,B[C
(trend A\B)
Age at onset of excessive substance use,
y, mean (SD)
N.A. 30.9 (11.3) 17.0 (2.7) t = 6.0, df = 61, P < 0.001
Gender, females (%) 59 (69) 13 (46) 19 (54) v
2 = 5.7, df = 2, P = 0.058 (trend A[B)
Bipolar disorder, type I (%) 53 (62) 15 (54) 22 (63) v
2 = 0.8, df = 2, P = 0.683
Family history, n (%) 30 (35) 8 (29) 22 (63) v
2 = 9.5, df = 2, P = 0.009, A, B\C
Excessive use of other substances, n (%) N.A. 5 (18) 13 (37) v
2 = 2.8, df = 1, P = 0.092
AAO age at onset of bipolar disorder, y years, No use no excessive substance use, Alcohol use excessive use of alcohol
Cannabis use: excessive use of cannabis. Family history includes affective or psychotic disorders
14
16
18
20
22
24
26
28
30
32
Primary BD Secondary BD
Excessive cannabis use Excessive alcohol use
AAO, y
Fig. 1 The relationship between age at onset (AAO), sequencing and
type of substance use. y years
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123The bivariate analyses revealed signiﬁcant correlations
between AAO and gender, age, BD type, excessive can-
nabis use, and sequencing (Table 4).
The multiple regression analysis showed that sequenc-
ing and excessive cannabis use signiﬁcantly predicted
AAO after adjusting for gender, age, and BD type. Age and
BD type also made signiﬁcant contributions to the model,
while gender contributed on a trend level (Table 5).
Excessive use of alcohol was not a signiﬁcant predictor nor
was family history or excessive use of other substances.
Lower age, BD II, primary BD, and excessive cannabis use
independently predicted an earlier onset, with gender and
age explaining 29% of the variance, type of BD 3%,
sequencing 5% and alcohol and cannabis use another 5%,
with a total of 41% of the variance explained. Without age
entered in the analysis, gender explained 5% of the vari-
ance, type of BD 3%, sequencing 2.5% and alcohol and
cannabis use another 13.5%, with a total of 24% of the
variance explained. Since sequencing was entered before
cannabis use in the analyses, cannabis use appeared to
predict an earlier onset regardless of whether it preceded or
followed the onset of the BD.
Discussion
The main ﬁnding of the present study was that excessive
cannabis use was associated with an earlier onset after
adjusting for possible confounders, while excessive alcohol
users had a later onset of the BD. Moreover, the mean age
at onset of excessive cannabis use preceded the AAO of
BD, while the reverse was the case with alcohol.
We found clear differences between the alcohol users
and the cannabis users. In addition to a later onset, the
alcohol users were older, had a later onset of the excessive
use, a lower prevalence of family history, and lower rates
of use of other substances compared with the cannabis
users. This has, to our knowledge, not been shown before.
Our ﬁndings also suggest differences in sequencing
between the alcohol and the cannabis users; for the alcohol
users, the mean AAO was earlier than the mean age at
onset of the excessive substance use, while for the cannabis
users, the mean AAO was later than the mean age at onset
of the excessive substance use. There was, however, no
interaction effect between type of substance use and
sequencing on AAO.
An earlier onset of excessive cannabis use compared
with excessive alcohol use could be a societal phenomenon
rather than related to BD. Whether the age at onset of
substance use disorders differs between substances has to
our knowledge not been investigated in a general popula-
tion sample. However, in a study of the age at ﬁrst use of
different substances, the age distribution curves were very
similar for alcohol and cannabis, both peaking in late
Table 4 The correlations between AAO and sociodemographic and
clinical variables
Variable AAO
Age 0.52**
Gender -0.22**
BD type (I versus II) -0.19*
Family history of affective/psychotic disorder -0.15
Age at onset of excessive substance use 0.54**
Excessive cannabis use -0.19*
Excessive alcohol use 0.13
Excessive use of other substances -0.14
Sequencing 0.19*
Data are expressed as Pearson correlations
AAO Age at onset
* p\0.05; ** p\0.01
Table 5 Multiple regression analysis of the effect of independent variables on age at onset
Block no., variable R
2 Change Beta (SE) 95% Conﬁdence Interval for B tP value
Constant 17.33 (10.30 to 24.36) 4.87 \0.001
1
Female 0.29 -2.42 (1.27) (-5.43 to -0.17) -1.91 0.058
Age 0.36 (0.06) (0.25 to 0.46) 6.48 \0.001
2
BD I 0.03 -2.73 (1.23) (-5.16 to -0.30) -2.22 0.028
3
Secondary BD 0.05 8.20 (1.79) (4.67 to 11.72) 4.59 \0.001
4
Excessive cannabis use 0.05 -6.01 (1.8) (-9.59 to -2.43) -3.32 0.001
Excessive alcohol use -0.33 (1.43) (-3.16 to 2.50) -0.23 0.817
Final model, R
2 = 0.41, F = 16.65, P\0.001
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123adolescence [43]. The later onset in alcohol users compared
with cannabis users may thus indicate that different
mechanisms are involved in the relationships between the
development of BD and these two most frequently used
substances. However, due to the present study’s cross-
sectional and naturalistic design, the ﬁndings are primarily
hypothesis generating. Taken together, our ﬁndings may
indicate that cannabis to a greater extent than alcohol
inﬂuences the onset of BD. This is in line with two recent
studies on acutely ill patients with a broad spectrum of
psychotic disorders, showing that cannabis abuse/depen-
dence was associated with an earlier onset of the psychotic
disorders after adjusting for abuse/dependence of other
substances including alcohol [44, 45]. Our ﬁndings indicate
that the association between AAO and excessive cannabis
use is present also in a pure BD sample. This is in line with
the growing evidence that cannabis use is a risk factor for
developing manic symptoms and BD [37–39], while alco-
hol abuse seems to increase the risk for depressive rather
than manic symptomatology [36, 46]. Furthermore, in a
recent study on prodromes of ﬁrst manic psychotic episode,
68% of patients were found to have substance use disorders
in the prodromal phase, of which 82% used cannabis [47].
Also, it is fairly well established that cannabis use com-
poses a risk factor for the development of psychosis/
schizophrenia [48]. Cell toxicity or disruption of neuro-
transmitter coordination caused by long-term heavy can-
nabis use has been suggested as a possible mechanism
behind this increased risk [49]. The fact that schizophrenia
and BD have many clinical features in common as well as
overlapping pathophysiology [50] increases the plausibility
that cannabis use may act as a risk factor also in BD.
The association between cannabis use and early onset in
the current study was present also after adjusting for
sequencing and appears to exist also when the excessive
use develops after the BD. This indicates that an early
onset increases the risk of subsequently developing
excessive cannabis use. This is in accordance with earlier
ﬁndings of an association between early BD onset and drug
abuse [19, 51], which may have several explanations. Some
authors have proposed that patients with early onset may
share a common increased genetic vulnerability mediating
both BD and excessive drug use [13]. Family history did
not independently predict AAO in the present study.
However, the family history rates of affective/psychotic
disorders among the cannabis users were high. Having a
close family member with a severe psychiatric disorder in
addition to experiencing affective episodes early in life
may also represent a substantial psychosocial burden,
leaving the patient at increased risk for illicit substance use.
The present ﬁnding that cannabis use predicts an earlier
onset regardless of sequencing is in contrast to earlier
ﬁndings of a later onset of BD secondary to cannabis [29].
This discrepancy could be due to differences in method-
ology and sample characteristics. One explanation may be
the high family history rates in our sample of excessive
cannabis users, on which no data were presented in the
previous study. Higher family history rates may indicate
high vulnerability for BD, which may interact with
excessive cannabis use to cause an early onset in these
patients. The complex relationship between AAO, type of
substance used, sequencing and family history should be
further explored in a greater sample allowing comparisons
on several subgroup levels.
One possible explanation for the association between
early onset of BD and excessive cannabis use could be a
cohort effect, i.e. that people born in the last decades may
be at greater risk for developing excessive cannabis use
than patients born earlier due to trends in substance use or
increased availability. However, since excessive cannabis
use still predicted AAO after adjusting for age, this cannot
explain the ﬁnding. The association between earlier onsets
and cannabis use was also present after adjusting for family
history and excessive use of other substances. Thus, it is
unlikely the present ﬁndings can be explained in terms of
these potential confounders.
The present ﬁnding that secondary BD predicted a later
onset (relative to primary BD) is highly consistent with
earlier studies [26–31, 52]. We also demonstrate that this
effect remains signiﬁcant even after adjusting for several
variables known to be associated with AAO (gender, BD
type, family history, type of substance used), further sup-
porting the hypothesis that the excessive substance use may
trigger BD. We do not replicate earlier ﬁndings that family
history is associated with AAO [8], or that family history
rates are lower in secondary BD compared with primary
BD [27]. We do, however, demonstrate that the family
history rates are higher among the cannabis users compared
with the alcohol users and the non-users. Patients’ reports
of family history of psychiatric disorders are a somewhat
crude measure [53], which may explain these inconsis-
tencies. Furthermore, the full range of vulnerability mark-
ers and risk factors for BD are not yet known, thus other
factors may have confounded the results.
In the multivariate analyses, we found that BD II dis-
order independently predicted an earlier onset, with the
same trend for female gender. Recent studies on the
association between AAO, gender, and BD type are
somewhat diverging; one study reported earlier onsets in
females but no differences regarding BD type [12], while
another reported that males and BD I had an earlier onset
compared with females and BD II [3]. The latter ﬁnding is
in contrast to the present study, while the former showed
similar results. This suggests that gender and BD type are
relevant when investigating AAO, but future studies are
needed to clarify these questions. Also, the ﬁndings of the
Eur Arch Psychiatry Clin Neurosci (2011) 261:397–405 403
123present study suggest that the prevalence of excessive
cannabis use could account for differences between popu-
lations in AAO.
The present study has some limitations. Data on sub-
stance use and illness characteristics including AAO were
gathered retrospectively, risking recall bias. There is, how-
ever, no reason to believe that this should affect the sub-
groups differently. Furthermore, some of the subgroups in
the bivariate analyses are small,increasingthe risk of type II
errors. Lastly, a control population in which the age at onset
of excessive cannabis versus alcohol use was investigated
would have provided data indicating whether these differ-
ences are societal phenomena or related to the BD.
Conclusion
Excessive cannabis use is associated with an early onset
regardless of whether it precedes or follows the BD, while
excessive use of alcohol or other substances is not inde-
pendently associated with AAO. General excessive sub-
stance use prior to BD onset is associated with a later onset.
The relationship between cannabis use and BD onset
should be further investigated in prospective studies.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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